PR Newswire: news distribution, targeting and monitoring
2013
See more news releases in Banking & Financial Services  | Health Care & Hospitals  | Medical Pharmaceuticals  | Pharmaceuticals  | Clinical Trials & Medical Discoveries

Edison Pharmaceuticals, Inc. Closes Financing

Capital Directed to EPI-A0001 and EPI-743 Approval Trials

Share with Twitter Share with LinkedIn
Share with Repost.us

MOUNTAIN VIEW, Calif., Sept. 13, 2011 /PRNewswire/ -- Edison Pharmaceuticals, Inc. announced today that it has closed a Series E Preferred Financing. Capital raised will fund US and European approval trials for the company's clinical candidates, EPI-A0001 and EPI-743. Terms of the financing were not disclosed.

Edison Pharmaceuticals

Edison Pharmaceuticals is a patient- and physician-founded company devoted to developing new medicines to transform the lives of children and adults diagnosed with rare and neglected diseases. Currently, the company is focused on inherited mitochondrial diseases for which there are no approved drugs. These conditions are life-threatening and highly debilitating. Edison's specialized skill set spans the discovery, development, and translation of redox-based drugs.

edisonpharma.com

SOURCE Edison Pharmaceuticals, Inc.



RELATED LINKS
http://www.edisonpharma.com

More by this Source

Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
Mar 28, 2013, 08:55 ET

Edison Pharmaceuticals & Bambino Gesu Children's Hospital Announce Initiation of EPI-743 Phase 2 Cobalamin C Deficiency Syndrome Clinical Trial
Feb 19, 2013, 00:01 ET

Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Friedreich's Ataxia Clinical Trial
Jan 07, 2013, 00:01 ET

View All News by this Source

Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 
Area to test
Advanced Search
Search
  
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire